Enzon Pharmaceuticals Inc

ENZN

$0.39

+123.2% last 12 months

Market Cap

$29.3 Million

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$0.18 - $0.85

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

-13.75x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $29.3 Million
Enterprise Value -$18.6 Million
Dividend Yield $0.00 (0.0%)
1 Year Return +123.2%
52-Week High $0.85
52-Week Low $0.18
Beta 0.0
Outstanding Shares 74.2 Million
Avg 30 Day Volume 87.9 Thousand

Valuation

P/E Ratio -13.75
PEG -17.22
Earnings per Share -$0.03
Price to Sales Ratio Infinity
Price to Book Ratio Infinity
Revenue to Enterprise Value -26.31
EBIT to Enterprise Value 28.15
Total Debt to Enterprise Value -0.0
Debt to Equity 0.0

Profitability

Revenue $706 Thousand
Gross Profit $706 Thousand
EBIT -$660 Thousand
Net Income -$2.13 Million
Profit Margin -301.98%
Quarterly Earnings Growth (YoY) +79.9%
Return on Equity -4.48%
Return on Assets -4.45%
Return on Invested Capital -1.39%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

57,500 shares sold (1 transactions)

No purchases

No sells

Q1 2021 Q2 2021 Q3 2021 Q4 2021

About Enzon Pharmaceuticals Inc

CEO: Andrew Rackear

Industry: Biological Product (except Diagnostic) Manufacturing

Enzon Pharmaceuticals, Inc is a pharmaceutical company engaged in developing therapeutics to patients whose needs are unmet. Its headquarters is now in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties.

Similar stocks

Nektar Therapeutics
Enanta Pharmaceuticals Inc
AMGEN Inc.
XOMA Corp
Vertex Pharmaceuticals, Inc.
Merck & Co Inc
Gilead Sciences, Inc.
Pfizer Inc.

News